STOCKHOLDERS' EQUITY (Details Textual) - USD ($)
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
Jan. 06, 2015 |
Mar. 31, 2015 |
Jan. 31, 2015 |
Oct. 17, 2014 |
Jul. 31, 2014 |
Mar. 31, 2015 |
Mar. 31, 2014 |
Dec. 31, 2014 |
Dec. 31, 2013 |
Dec. 31, 2012 |
Warrants To Purchase Common Stock |
|
7,002,774
|
|
|
|
7,002,774
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|
|
|
|
|
786,696
|
|
2,536,935
|
0
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
|
|
|
$ 1.00
|
|
$ 0.53
|
$ 0
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|
|
|
|
|
|
|
2,616,041
|
|
|
Common Stock, Shares Authorized |
|
75,000,000
|
75,000,000
|
|
|
75,000,000
|
|
37,000,000
|
37,000,000
|
|
Common Stock, Par or Stated Value Per Share |
|
$ 0.001
|
|
|
|
$ 0.001
|
|
$ 0.001
|
$ 0.001
|
|
Preferred Stock, Shares Authorized |
|
5,000,000
|
|
|
|
5,000,000
|
|
8,000,000
|
8,000,000
|
|
Preferred Stock, Par or Stated Value Per Share |
|
$ 0.001
|
|
|
|
$ 0.001
|
|
$ 0.001
|
$ 0.001
|
|
Equity Incentive Plan Description |
|
|
In accordance with the rules of the TSX Venture Exchange regarding equity incentive plans, the number of shares that can be reserved for issuance under the 2011 Plan is equal to 20% of the Companys common stock outstanding at the completion of our initial public offering.
|
|
|
In accordance with the rules of the TSX Venture Exchange regarding equity incentive plans, the number of shares that can be reserved for issuance under the 2011 Plan is equal to 20% of the Companys common stock outstanding at the completion of the offering.
|
|
|
|
|
Common Stock, Capital Shares Reserved for Future Issuance |
|
3,843,258
|
|
|
|
3,843,258
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value |
|
|
|
|
|
$ 0.38
|
|
$ 0
|
$ 0
|
|
Share-based Compensation |
|
|
|
|
|
$ 145,514
|
$ 362
|
$ 305,018
|
$ 16,207
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period |
|
|
|
|
|
55,548
|
|
0
|
0
|
|
Proceeds from Stock Options Exercised |
|
|
|
|
|
$ 55,548
|
$ 0
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|
|
|
|
|
|
|
933,617
|
15,596
|
0
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms |
|
|
|
|
|
|
|
8 years 7 months 20 days
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding |
|
|
|
|
|
|
|
$ 646,768
|
$ 0
|
$ 0
|
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized |
|
|
|
|
|
|
|
365,000
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
|
|
|
|
|
$ 2,489,999
|
|
|
Debt Conversion, Converted Instrument, Amount |
|
|
|
|
|
|
|
0
|
$ 785
|
|
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|
|
|
|
|
|
|
$ 86,129
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period |
|
|
|
|
|
0
|
|
91,095
|
1,307,728
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
|
|
|
|
|
7 years 6 months 18 days
|
|
9 years 6 months 25 days
|
8 years 3 months 4 days
|
9 years 3 months 4 days
|
Two Agent [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period |
|
55,548
|
|
|
|
|
|
|
|
|
Proceeds from Stock Options Exercised |
|
$ 55,548
|
|
|
|
|
|
|
|
|
Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Issued |
|
|
|
|
100,000
|
|
|
|
|
|
Chief Executive Officer [Member] |
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Expiration Term |
|
|
|
|
|
|
|
10 years
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
|
|
|
$ 0.26
|
|
|
Class of Warrant or Right, Issued |
|
|
|
|
|
|
|
797,075
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights, fair value |
|
|
|
|
|
|
|
$ 0.21
|
|
|
Employee Stock Option [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|
|
|
|
|
|
|
127,532
|
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
|
|
|
|
|
$ 0.26
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value |
|
|
|
|
|
|
|
$ 0.87
|
|
|
Payments of Stock Issuance Costs |
|
|
|
|
|
$ 39,201
|
|
|
|
|
Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|
|
|
|
|
|
|
6,230
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
|
|
|
|
|
|
|
10 years
|
|
|
Employee Stock Option [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period |
|
|
|
|
|
|
|
4 years
|
|
|
Employee Stock Option [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period |
|
|
|
|
|
|
|
2 years
|
|
|
Employee Stock Option [Member] | Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
|
|
|
|
|
$ 0.73
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value |
|
|
|
|
|
|
|
0.52
|
|
|
Employee Stock Option [Member] | Employees [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
|
|
|
|
|
0.26
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value |
|
|
|
|
|
|
|
$ 0.18
|
|
|
Compensation Options [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|
|
786,696
|
|
|
|
|
|
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
$ 1.00
|
|
|
|
|
|
|
|
Class of Warrant or Right, Title of Security Warrants or Rights Outstanding |
|
|
The Compensation Options expire on July 6, 2016. Each whole warrant issuable upon exercise of Compensation Options is exercisable to acquire one share of common stock at an exercise price of $2.00 per share at any time up to January 6, 2017, subject to the Companys right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days.
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
|
|
|
|
|
0
|
|
|
Conversion of Stock, Shares Issued |
5,400,000
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
|
|
|
|
|
$ 0
|
|
|
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|
|
|
|
|
|
|
0
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Title of Security Warrants or Rights Outstanding |
|
|
|
|
|
The warrants are exercisable through January 6, 2017 at a price of $2.00 per share. The warrants are subject to the Companys right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days.
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|
7,936,391
|
|
|
|
7,936,391
|
|
|
|
|
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Exercise Price |
|
$ 1.80
|
|
|
|
$ 1.80
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms |
|
|
|
|
|
2 years 7 months 6 days
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding |
|
$ 1,038,575
|
|
|
|
$ 1,038,575
|
|
|
|
|
Class of Warrant or Right, Expiration Term |
|
|
|
|
5 years
|
|
|
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
$ 0.26
|
|
|
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights, fair value |
|
|
|
|
$ 0.24
|
|
|
|
|
|
Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|
|
80,000,000
|
|
|
|
|
|
|
|
Common Stock, Shares Authorized |
|
|
75,000,000
|
|
|
|
|
|
|
|
Common Stock, Par or Stated Value Per Share |
|
|
$ 0.001
|
|
|
|
|
|
|
|
Preferred Stock, Shares Authorized |
|
|
5,000,000
|
|
|
|
|
|
|
|
Preferred Stock, Par or Stated Value Per Share |
|
|
$ 0.001
|
|
|
|
|
|
|
|
IPO and Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
Warrants To Purchase Common Stock |
|
|
6,975,000
|
|
|
|
|
|
|
|
Proceeds from Issuance or Sale of Equity |
|
|
$ 13,950,000
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
13,950,000
|
|
|
|
|
|
|
|
Class of Warrant or Right, Title of Security Warrants or Rights Outstanding |
|
|
Each whole warrant is exercisable to acquire one share of CohBar's common stock at a price of $2.00 per share at any time up to January 6, 2017, subject to CohBar's right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days.
|
|
|
|
|
|
|
|
Proceeds from Debt, Net of Issuance Costs |
|
|
$ 12,953,484
|
|
|
|
|
|
|
|
IPO [Member] |
|
|
|
|
|
|
|
|
|
|
Class Of Warrant Or Rights Issued During Period |
|
|
11,250,000
|
|
|
|
|
|
|
|
Share Price |
|
|
$ 1.00
|
|
|
|
|
|
|
|
Proceeds from Issuance of Warrants |
|
|
$ 11,250,000
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
11,250,000
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|
|
786,696
|
|
|
|
|
|
|
|
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
|
|
$ 1.00
|
|
|
|
|
|
|
|
Common Stock, Capital Shares Reserved for Future Issuance |
|
|
6,453,069
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
$ 11,250,000
|
|
|
|
|
|
|
|
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|
|
|
|
|
$ 749,386
|
|
$ 749,386
|
|
|
Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
Class Of Warrant Or Rights Issued During Period |
|
|
2,700,000
|
|
|
|
|
|
|
|
Proceeds from Issuance of Warrants |
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
2,700,000
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
Share Price |
|
|
|
|
|
|
|
$ 0.50
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
|
|
|
|
|
5,190,000
|
|
|
Preferred Stock, Par or Stated Value Per Share |
|
|
|
|
|
|
|
$ 0.001
|
|
|
Conversion of Stock, Shares Converted |
5,400,000
|
|
|
|
|
|
|
|
|
|
Conversion of Stock, Shares Issued |
|
|
5,400,000
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
|
|
|
|
|
$ 5,190
|
|
|
Deferred Finance Costs, Current, Net |
|
|
|
|
|
|
|
$ 59,920
|
|
|
Debt Conversion, Converted Instrument, Shares Issued |
|
|
|
|
|
|
|
420,000
|
|
|
Debt Conversion, Converted Instrument, Amount |
|
|
|
|
|
|
|
$ 210,000
|
|
|
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|
|
|
|
|
|
|
$ 0
|
$ 0
|
|
Series B Preferred Stock [Member] | Put Option [Member] |
|
|
|
|
|
|
|
|
|
|
Share Price |
|
|
|
$ 1.00
|
|
|
|
|
|
|
Series B Preferred Stock [Member] | IPO [Member] |
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
|
|
|
|
|
5,400,000
|
|
|
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|
|
|
|
|
|
|
$ 86,129
|
|
|
Series B Preferred Stock [Member] | IPO [Member] | Put Option [Member] |
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period |
|
|
|
2,700,000
|
|
|
|
|
|
|